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Precise endograft placement in the thoracic aorta is challenging due to the special local anatomy and unique hemodynamic
blood flow. We are employing many techniques together to launch the endograft precisely to the target location: various
debranching techniques to extend the proximal landing zone, magnified imaging with full exposition of the supra-arch
branches and the proximal landing area to achieve a clear and accurate view, screen markers of the landing target for
guidance of deployment, 1-2 cm proximally to the cranial landing marker before launching in case of any displacement,
steady deployment of the endograft in hypotensive status or within the temporary heart asystole period induced by
intravenous adenosine administration. If a balloon angioplasty or a proximal cuff is inevitable, the abovementioned
techniques should be repeated. Our single center results have proved the combined techniques for precise thoracic
endograft placement reliable, effective, simple and practical. ( J Vasc Surg 2009;49:1069-72.)Based on the experience of endovascular abdominal aortic
aneurysm repair (EVAR), thoracic endovascular aortic repair
(TEVAR) has been widely accepted in the past decade.1 One
of the differences between EVAR and TEVAR is the precise
placement of endograft. In understanding the mechanism of
endovascular aortic repair, it is similar to putting a tube in a
running river; accurate placement in the desired target is
crucial to the success. Precise deployment of the stent-graft is
quite challenging in TEVAR procedure owing to the special
local anatomy and unique hemodynamic blood flow.2,3 We
endeavored to employ a series of techniques to achieve the
precise placement of the endograft in our institution; the
results proved encouraging. The techniques for precise tho-
racic endograft placement are summarized here.
PATIENTS AND METHODS
The TEVAR results pooled in the database from July
1994 to December 2007 were retrospectively reviewed in
our single center. A total of 265 cases underwent TEVAR
procedures owing to a variety of thoracic lesions. All the
procedures were carried out under general anaesthesia by
the fixed TEVAR group in the operation room equipped
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doi:10.1016/j.jvs.2008.12.010with a mobile C-arm digital subtraction angiography
(DSA) machine (Pulsera; Philips BV, Orlando, Fla).
How I Do It. Besides the general condition evalua-
tion of the patient, the preoperative imaging assessment
using thin slice cross-sectional contrast-enhanced Com-
puted Tomography Angiogram (CTA), Magnetic Reso-
nance Angiogram (MRA), or Digital Subtraction Angiog-
raphy (DSA) is of great importance. Considering the
precise thoracic endograft placement and the long-term
results, we aggressively do debranching procedures to ex-
tend the proximal landing zone if the landing length is less
than 1.5 cm. With the adjunction of different debranching
techniques that have already been summarized and re-
ported, we are treating more and more complex thoracic
lesions with TEVAR procedures.4 This technique proved
helpful for precise thoracic endograft placement in TEVAR
owing to the extended landing zone. During the TEVAR
procedure, several techniques are adopted to achieve the
precise endograft placement: (1) Full exposition and accu-
rate view of the pathologic lesion and its related or involved
local anatomy are the prerequisite for the ensuing proce-
dures. The magnified aortography imaging accomplished
in the anterior left oblique with 40°-45°is usually able to
meet our demand; (2) Screen markers on the magnified
imaging with full exposition of the supra-arch branches and
the proximal landing area remain vital for guidance of the
endograft deployment to the landing target (Fig 1). In this
moment, it is also very important to keep the DSAmachine
and the patient in place with no occasional movement.
Then the delivery system should be negotiated steadily and
smoothly to the target location; (3) Put the cranial covered
part of the endograft 1-2 cm proximally to the landing
marker before launching is important in case of any dis-
placement (Fig 2); (4) Steady deployment of the endograft
according to the proximal landing marker on the closely
watched screen is the key procedure for the final result. For
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aorta with enough proximal landing zone, we just deploy
the endograft in the status of induced hypotention (70-90
mmHG) achieved with nitroglycerin or sodium nitroprus-
side. Retreat the cranial covered part of the endograft to the
proximal edge of the landing marker and then deploy it
steadily; stability of the whole delivery system and the super
stiff guide wire is of great importance for this step. For
Fig 1. Markers on the screen demonstrating the proximal landing
target, the thoracic lesion, and its related anatomy.
Fig 2. The black arrow indicates the cranial covered part of the
endograft is put proximally to the landing target before launching.complicated cases that will need placement of the thoracicendograft near the aortic arch or in the ascending aorta, we
normally deploy the endograft within the temporary heart
asystole period induced by intravenous bolus of adenosine.
While the endograft is in the desired position, 1 mg/kg
adenosinewas administered in a bolus intravenously, resulting
in immediate 20-30 seconds heart asystole (Fig 3). Thus, the
endograft can be precisely deployed in sufficient time without
interference of downward blood flow induced by cardiac
cycle. It is similar to putting a tube in a non-flowing river,
which is much easier andmore accurate than that in a running
river.
If a balloon angioplasty or a proximal cuff is inevitable,
the aforementioned techniques should be repeated.
RESULTS
Debranching techniques were used in 76 cases and the
technical success rate was 100%. All the cases were carried out
under guidance of markers on the screen with full exposed
magnified imaging. Temporary cardiac arrest was undertaken
in 168 cases. Precise positioning at amean 22mm from the
predetermined launch site was observed in all cases with
cardiac arrest; there was no proximal or distal migration oc-
currence during deployment of the endograft. On the con-
trary, four cases had distal migration of more than 2 cm in the
non-cardiac arrest cohort, which needed a proximal cuff to
overcome the proximal endoleak. Among the four cases with
distalmigration, three cases had aGoreTAGdevice (W.L.Gore
& Associates, Flagstaff, Ariz) and the other had an EndoFit
device (LeMaitre Vascular, Burlington,Mass; LeMaitre Vascular
now offers a next-generation version called the TAArget Tho-
racic Stent Graft, which has a redesigned delivery system and
improved external fixation). Ten cases had immediate proximal
type I endoleak, six cases were remedied with proximal cuff,
and two caseswere rescuedwith tri-lobe balloon,with two left
untreated. One intraoperative massive bleeding from ascend-
ing aortic debranching anastomosis was rescued with the aid
of pump. Neurological complications occurred in eight cases
Fig 3. Heart asystole happens immediately after bolus adminis-
tration of adenosine.including five strokes and three paraplegia (two in type IV
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rate was 6.5%. All the extra-anatomical bypasses remained
patent, all the stent-grafts implanted were patent, and there
was no stent-graft kinking or collapse or dislocation.
DISCUSSION
Improved understanding of the native thoracic aortic
environment where thoracic endografts are placed may aid in
technique application for precise endograft positioning. Dy-
namic electrocardiographically-gated 64-slice cine CTA dem-
onstrated that dynamics of the thoracicaortaandthearchvessels
are impressive. There is a wide range of three-dimensional
motions, and the aortic pulsatility is not evenly distributed.2,3
To launch the endograft in the predetermined landmark, we
should be very clear about the target location and its related
anatomy. Therefore, magnified DSA imaging with full expo-
sition of the arch and the supra-arch vessels is the prerequisite
for further manipulation. Markers on the DSA screen provide
accurate information where the endograft should be landed.
Stability of the table and the patient should be kept in mind
after angiogram. Most of the thoracic endografts currently
available are unable to reposition once deployed.What we did
differently from others in most of the cases for precise deploy-
ment is to induce temporary cardiac asystole using intravenous
bolus injection of adenosine which has already been proven
safe and simple.4-6 Normally 60-90 mg adenosine can induce
20-30 seconds of cardiac arrest, which is sufficient for precise
deployment of the stent-graft. The temporary cardiac asystole
happens immediately after the bolus injection and recovers
automatically within 20-30 seconds. For endografting of the
descending thoracic lesions, we normally reduce the systolic
blood pressure to 80-90 mm HG during deployment. This
pharmacologically induced transient asystole or hypotension
technique permits precise deployment of both self-expanding
and balloon-expandable stent-grafts. Regardless, we do be-
lieve that anymethod to eliminate or reduce the force of aortic
flow on the thoracic endoprostheses is helpful for precise
thoarcic endograft placement. Rapid right ventricular pacing
is now used in many centers.7,8 This technique is widely
applied for treating bradyarrhythmias. A 5-F bi-polar or quad-
polar cardiac pacing catheter should be positioned in the right
ventricular apex via the femoral or jugular vein and the pacing
threshold should be checked once installed. An acceptable
threshold was 1 mV. The pacemaker output was set to 4-5
mV. Ventricular pacing at a rate of 130 to 180 beats per
minute can lower the systolic pressure to 50-60mmHG,7 and
160 to 200 beats per minute can reduce the systolic pressure
to 20-30mmHG.8 Themechanism involves loss of atrioven-
tricular synchrony and reduction of ventricular filling time,
resulting in decreased left ventricular preload, stroke volume,
and cardiac output. The advantage of thismaneuver is that it is
controllable and repeatable. The systolic pressure will drop
down immediately andmarkedly once activation initiates, and
it will almost immediately return to normal after inactivation
of the pacemaker. Anothermethod is partial right atrial inflow
occlusion,9,10 using a compliant occlusion balloon introduced
through the femoral or jugular vein into the right atrium to
inflate in the inferior or superior vena cava to occlude theinflow to the right atrium to reduce the cardiac preload.
Potential complications of this technique include balloon
rupture or migration and intracranial venous hypertension in
the case of occlusion of the superior vena cava. Both tech-
niques not only require knowledge of right cardiac anatomy
but also need more apparatus or equipment and add more
interventional maneuver to the TEVAR procedure. They
wouldmake the TEVAR proceduremore complicated; there-
fore we do not apply them.We do believe that pharmaceutical
approach ismore simple and practical; it is easy to use anddoes
not need any additional equipment or apparatus.We have not
encountered any adverse effect using this technique.
CONCLUSION
Our single center experience demonstrated that a com-
bination of debranching technique for extension of proxi-
mal landing zone, clear markers on the magnified DSA
screen for guidance of positioning, induced hypotension,
or temporary cardiac asystole for abbreviation of hemody-
namic compromise can result in a precise endograft place-
ment in TEVAR. The above techniques are safe, effective,
and simple in selected patients and in experienced hands.
They may eventually emerge as the preferred method for
precise thoracic endograft placement in TEVAR.
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The authors have developed an excellent thoracic endovascu-
lar aneurysm repair (TEVAR) practice with commendable results.
The techniques described in this article are useful for TEVARwhen
using single-stage delivery systems where the outer jacket is slowly
withdrawn as the endograft self-expands. Specifically, beginning
placement “1 to 2 cm proximally to the landing marker” is neces-
sary when the strong forces required to pull back a stiff outer jacket
risk distal dislodgement of the entire system.
Adenosine arrest is useful when there are potential windsock
effects during a prolonged deployment sequence. Interestingly,
vasodilator-induced arterial hypotension may actually increase car-
diac output in some patients by reducing afterload.
Additional supplementary techniques may be used with these
and other types of delivery systems. For example, modern fixed
imaging systems allow three-dimensional roadmapping without
the need for marking on the monitor. Multiple gantry angle
imaging can be very useful when the endograft is not deploying
perpendicular to the imaging beam, parallel to the aortic neck, and
perpendicular to the origin of the closest preserved aortic branch.partially constrained after the outer jacket is withdrawn, repeated
imaging in multiple planes with small volumes of contrast can be
performed before and after fine repositioning, and then the en-
dograft is completely deployed in the final stage. Repeat arteriog-
raphy and repositioning are particularly useful when removal of a
stiff jacket alters the thoracic arch anatomy or the angulation of the
endograft.
Specific thoracic guidewires with precurved shapes for the
thoracic arch, brachial-femoral “tug-of-wire” technique, tip de-
flection tricks, and tensioning the guidewire along the greater
curve can also be used to improve precision with rapid deployment
systems that do not require induced hypotension or cardiac arrest.
In the future, deployment systems that allow trial deployment,
complete reconstraining, repositioning, and redirecting the en-
dograft will allow TEVAR practitioners ideal control over the
placement of the devices in this challenging thoracic aortic envi-
ronment. Until then, these and other techniques that Drs Lefeng
Qu and Dieter Raithel have described should be familiar to the
TEVAR practitioner.
